The Enterprise Value as of December 2025 (TTM) for GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) is 424.12B

According to GlaxoSmithKline Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 424.12B. This represents a change of -9.16% compared to the average of 466.87B of the last 4 quarters.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Historical Enterprise Value (quarterly & annually)

How has GLAXO.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of GlaxoSmithKline Pharmaceuticals Limited over the last ten years is 270.41B. The current 424.12B Enterprise Value has changed 15.58% with respect to the historical average. Over the past ten years (40 quarters), GLAXO.NS's Enterprise Value was at its highest in in the June 2025 quarter at 574.04B. The Enterprise Value was at its lowest in in the December 2013 quarter at -855180000.00.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GlaxoSmithKline Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Average Enterprise Value

How has GLAXO.NS Enterprise Value performed in the past?

The current Enterprise Value of GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Enterprise Value vs. Peers

How is GLAXO.NS’s Enterprise Value compared to its peers?

GlaxoSmithKline Pharmaceuticals Limited’s Enterprise Value is greater than Gland Pharma Limited (264.57B), greater than Gland Pharma Limited (264.57B), less than Abbott India Limited (610.97B), less than Abbott India Limited (610.97B), less than Laurus Labs Limited (575.43B), less than Laurus Labs Limited (575.43B), less than Glenmark Pharmaceuticals Limited (555.43B), less than Glenmark Pharmaceuticals Limited (555.43B), greater than Ipca Laboratories Limited (380.84B), greater than Ipca Laboratories Limited (380.84B),

Build a custom stock screener for GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlaxoSmithKline Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GlaxoSmithKline Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.